Investor Overview

Pardes is a clinical-stage biopharmaceutical company created by and for this moment to solve pandemic-sized problems, starting with COVID-19. We are applying modern reversible-covalent chemistry as a starting point to develop novel drugs while reimagining the patient journey to access these medicines.
Learn More

Stock
Quote

Volume:
03/07/2023 8:51 AMEST

Webcasts

02/14/2023
at 1:40 PM EST
SVB Securities Global Biopharma Conference
11/15/2022
at 12:00 AM PST
Jefferies London Healthcare Conference
09/14/2022
at 10:30 AM EDT
H.C. Wainwright 24th Annual Global Investment Conference
06/09/2022
at 11:30 AM EDT
Jefferies Healthcare Conference

Financial Information

There are no SEC filings available.

Contact
IR

Send us an investor-related question using the form below.